TheraRadar
Data updated: May 26, 2026

HELIUM, USP (helium)

Respiratory Approved 2013-07-14
14
Indications
--
Phase 3 Trials
12
Years on Market

HELIUM, USP Approval History

2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Original
New Indication
New Form
Label Update
15 FDA actions from 2013 to 2021
Jul 2021 ORIGINAL
Update · Medical Gas
Jun 2020 ORIGINAL
Update
Oct 2019 ORIGINAL
Update · Medical Gas

What HELIUM, USP Treats

14 FDA approvals

Originally approved for its first indication in 2013 . Covers 14 distinct patient populations.

  • Other (14)
🔬

Active Pipeline

Pro

Ongoing clinical trials by development phase

Loading...

Key Completed Trials

Pro

Completed studies with published results, ranked by significance

Loading...
📊

Trial Timeline

Full development history with FDA approval milestones

|
Loading...
Understanding FDA Approval Types
Count Type What it means
- ORIG Original approval - drug first enters market
- SUPPL - Efficacy New indication (new disease/condition approved)
- SUPPL - Labeling Label text changes (warnings, dosing updates)
- SUPPL - Manufacturing Production changes (new facility)
- SUPPL - Chemistry Formulation changes (new dosage strength)

Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.

HELIUM, USP FDA Label Details

Track HELIUM, USP with TheraRadar Pro

Watchlist alerts, full database access, CSV exports across 14,000+ drugs.

Upgrade to Pro

Data Sources

Data sourced from official FDA and NIH databases. Click links to verify on original sources.